MAPT and Alzheimer disease: Experimental studies exploring the role of epigenetic mechanisms in neurodegenerative diseases have found that DNA methylation variations may affect beta-amyloid (Aβ) and tau deposition in AD, and expression of α-synuclein in PD [29,30].